venetoclax
Roche,Abbvie
[]
 interesting similar results from study presented by our fellow lydia chow at #ash22 61 pts who got upfront hma/vene median survival after relapse/ref disease approx 3 months 
Assistant Professor BMT/leukemia @ USC, Allo transplant_leukemia, palliative care & Global Oncology Alumnus @UMN_MPH @Mayo_PaliCare @StanfordBMT @AKUGlobal